OTCMKTS:CDXI Cardax (CDXI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Cardax Stock (OTCMKTS:CDXI) Get Cardax alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cardax, Inc. (OTCMKTS:CDXI) is a clinical-stage biotechnology company focused on the discovery and development of novel anti-inflammatory drug candidates. The company’s proprietary platform utilizes phospholipid-conjugated formulations of astaxanthin designed to enhance bioavailability and target chronic inflammatory and fibrotic conditions. Cardax’s lead program, CARD-024, is advancing in preclinical development for the treatment of atherosclerosis and related cardiovascular diseases. In addition to its cardiovascular pipeline, the company is exploring immuno-oncology and gastrointestinal indications, leveraging its core technology to create differentiated therapeutic assets across multiple disease areas. Headquartered in Honolulu, Hawaii, Cardax conducts its research and development activities primarily within the United States. The management team combines expertise in pharmaceutical sciences, clinical operations and regulatory affairs, positioning the company to progress its candidates through critical preclinical and early clinical milestones.AI Generated. May Contain Errors. Read More Receive CDXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardax and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CDXI Stock News HeadlinesCardax Inc.December 14, 2025 | wsj.comCardiometabolic Disease Market Size Worth USD 868.45 Billion by 2032 at 24% CAGR – Report by Market Research Future (MRFR)June 2, 2023 | finance.yahoo.comGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.June 17 at 1:00 AM | Behind the Markets (Ad)CDXI.PK - Cardax Inc | Stock Price & Latest News | ReutersOctober 10, 2022 | reuters.comCardax, Inc. (CDXI)October 4, 2022 | finance.yahoo.comCDXI After-Hours QuotesJanuary 20, 2022 | nasdaq.comCardax Inc. makes several moves to reduce costsSeptember 2, 2021 | news.yahoo.comCardax Refocuses on ZanthoSyn® Consumer Health BusinessAugust 31, 2021 | finance.yahoo.comSee More Headlines CDXI Stock Analysis - Frequently Asked Questions How do I buy shares of Cardax? Shares of CDXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cardax own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardax investors own include Ashford Hospitality Trust (AHT), Peabody Energy (BTU), PlayAGS (AGS), Assertio (ASRT), Astronics (ATRO), Alliance Resource Partners (ARLP). Company Calendar Today6/17/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CDXI CIK1544238 Webwww.cardaxpharma.com Phone(808) 457-1400Fax808-237-5901Employees10Year Founded2006Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares800,000Free Float566,000Market CapN/A OptionableNot Optionable Beta0.65 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:CDXI) was last updated on 6/17/2026 by MarketBeat.com Staff. From Our PartnersSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX is offering you shares. Don't take them.SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...Behind the Markets | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
